Health ❯Medical Research ❯Neurology

Alzheimer's Disease

Cognitive Impairment Biomarkers Hypertension IDO1 Inhibitors Phases of Alzheimer's Xenon Treatment Gene Expression Clinical Trials Brain Samples Protein Research Diagnostic Tests Neurovascular Unit Dopamine and Neprilysin Interaction

Newborns’ Blood p-Tau217 Levels Surpass Those in Alzheimer’s Patients

Insights into infants’ natural clearance of p-Tau217 may inform protective strategies against Alzheimer’s disease.

Insulin Resistance Blood Test Forecasts Rapid Alzheimer’s Decline

FDA Approves 95% Sensitive Blood Test for Alzheimer’s

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

Xenon Gas Shows Promise as Potential Alzheimer's Treatment in Mouse Study

New Study Reveals Alzheimer's Progresses in Two Distinct Phases

Cancer Drug Shows Promise in Treating Early-Stage Alzheimer’s

Dopamine Shows Promise in Reducing Alzheimer's Plaques

MIT Study Identifies Key Factors in Alzheimer's Vulnerability and Cognitive Resilience